PATENT & Technology LICENSE AGREEMENT AGT. No. A2014-0165Microlin Bio, Inc. • February 28th, 2014 • Pharmaceutical preparations • Ohio
This Patent & Technology License Agreement is between the Licensor and the Licensee identified below (collectively, “Parties”, or singly, “Party”).
PATENT & Technology LICENSE AGREEMENT AGT. No. A2014-0294Microlin Bio, Inc. • February 28th, 2014 • Pharmaceutical preparations
This Patent & Technology License Agreement is between the Licensor and the Licensee identified below (collectively, “Parties”, or singly, “Party”).
AMENDMENT NO. 1 TO LICENSE AGREEMENTLicense Agreement • February 28th, 2014 • Microlin Bio, Inc. • Pharmaceutical preparations
This Amendment No. 1 to License Agreement (“Amendment”), having an effective date of January 15, 2014 (“Amendment Effective Date”), is made and entered by and between Ohio State Innovation Foundation, located at 1524 North High Street, Columbus, Ohio 43201 (“OSIF”) and MicroLin Bio, Inc., a New York corporation located at 302A W. 12th Street, Suite 114, New York, NY 10014 (“Licensee”).
Form of Lock-Up AgreementLock-Up Agreement • February 28th, 2014 • Microlin Bio, Inc. • Pharmaceutical preparations
This Lock-Up Agreement (this “Agreement”) is being delivered to you in connection with the proposed Underwriting Agreement (the “Underwriting Agreement”) between Microlin Bio, Inc., a Delaware corporation (the “Company”), and Sunrise Securities Corp. (“Sunrise”), as representative of a group of underwriters (collectively, the “Underwriters”), to be named therein, and the other parties thereto (if any), relating to the proposed initial public offering (the “Offering”) of shares of common stock, par value $0.000001 per share (the “Common Stock”), of the Company.
